< 1 minute read
Oct. 6, 2021

NBI-921352: A NaV1.6 Inhibitor

NBI-921352

highly selective NaV1.6 sodium channel inh. entering Ph. II for seizures (100 mg TID) arylsulfonamide class bioRxiv Xenon Pharmaceuticals, Burnaby, Canada

drughunter.com
Drug Hunter Team

The Xenon NaV1.6 Inhibitor, NBI-921352 , is remarkably selective for the NaV1.6 sodium channel over other isoforms (IC50 = 51 nM, 756x vs. NaV1.1, 134X vs. NaV1.2, 276X vs. NaV1.7, >583X vs. 1.3, 1.4, 1.5). The molecule is It is being developed to treat pediatric patients with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE) and [...]

Loading...

twitterlinkedinemail

Other molecules you may be interested in